Defining and Treating Borderline Resectable Pancreatic Cancer.
Opinion Statement: Patients with borderline resectable pancreatic ductal adenocarcinoma (BR PDAC) should receive preoperative chemotherapy with or without radiation therapy, with the intent to eradicate occult metastatic cancer cells, to select patients with a "locally dominant cancer phenotype" for...
| Publicado en: | Current Treatment Options in Oncology Vol. 21; no. 9 |
|---|---|
| Autores principales: | , , |
| Formato: | research Journal Article |
| Publicado: |
Springer Nature
Sep2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |